In a trial, Gossamer Bio's PAH treatment candidate seralutinib reduced the resistance blood faces moving into the lungs over ...

Tectonic Therapeutic said the findings support the design and population for Phase 2 APEX trial, which will test TX45 in ...

Merck is ending a Phase 3 trial of Winrevair early so all PAH patients in HYPERION can start active treatment with the drug ...

The LungFit PH device was approved ini 2022 by the U.S. Food and Drug Administration and the European Union to treat PPHN.

Men with PAH had a larger right heart size and worse survival than women, independent of body size and functional status, a ...

I’ve written more than once about the support I’ve received from my immediate family throughout my health journey. I’m fortunate to have parents and siblings who are invested in my health and willing ...